Endoscopic polypectomy performed in clinic for chronic rhinosinusitis with nasal polyps: study protocol for the EPIC multicentre randomised controlled trial
Authors:
Open Access
Abstract
Introduction Chronic rhinosinusitis (CRS) is common, with a Canadian prevalence of 5%, and associated with significant morbidity. Understandably, CRS impairs workplace productivity but that productivity substantially increases following surgical treatment. CRS with nasal polyps (CRSwNP), the most common type of CRS, is usually treated with a combination of medications and endoscopic sinus surgery (ESS). Historically, surgical treatment has only been performed in the operating room at a cost of about $C3500. However, recent studies have shown that a de-escalated procedure, endoscopic polypectomy performed in clinic (EPIC), can provide an improvement in patient symptoms to levels equal to those for ESS. Moreover, EPIC has additional proposed advantages including shorter recovery time, significantly lower cost to the healthcare system and shorter wait time for the patient. There is currently insufficient evidence to draw conclusions about the superiority of polypectomy or ESS for the management of CRSwNP. Methods and analysis We designed a multicentre, open-label, randomised controlled trial to evaluate whether EPIC was non-inferior to the current clinical standard, ESS for the treatment of CRSwNP. The primary outcome is the Sinonasal Outcome Test-22 score measured at baseline and at 3 months after surgery. Other outcomes include peak nasal inspiratory flow, quality of life measured by the EuroQoL 5 Dimensions 5 Levels questionnaire and work impairment using the Work Productivity and Activity Impairment Questionnaire. We aim to recruit 140 patients from sites across Canada. Participants will be randomly assigned to EPIC or ESS and followed up for 3 months in clinic after the procedure. Additionally, participants will enter a 5-year long-term follow-up period. Ethics and dissemination This study was approved by the Ottawa Health Sciences Network Research Ethics Board for all sites in Ontario, Canada (study number CTO0801). Sites located outside of Ontario obtained approval from their local/institutional research ethics board. Trial registration number NCT02975310.Keywords
Funding Information
- Medtronic (Physician-Sponsored Research Grant - A 1284455)
- Canadian Institutes of Health Research (PJT148734)
- Physicians' Services Incorporated Foundation (N/A)
This publication has 30 references indexed in Scilit:
- Health state utility values in patients undergoing endoscopic sinus surgeryThe Laryngoscope, 2011
- Multicenter Assessment of the Iowa Satisfaction with Anesthesia Scale, an Instrument that Measures Patient Satisfaction with Monitored Anesthesia CareAnesthesia & Analgesia, 2011
- Impact of chronic rhinosinusitis on work productivity through one‐year follow‐up after balloon dilation of the ethmoid infundibulumInternational Forum of Allergy & Rhinology, 2011
- Long‐term outcomes from the English national comparative audit of surgery for nasal polyposis and chronic rhinosinusitisThe Laryngoscope, 2009
- The health and resource utilization of Canadians with chronic rhinosinusitisThe Laryngoscope, 2008
- Estimating mean QALYs in trial‐based cost‐effectiveness analysis: the importance of controlling for baseline utilityHealth Economics, 2004
- Something old, something new, something borrowed, something blue: a framework for the marriage of health econometrics and cost‐effectiveness analysisHealth Economics, 2002
- Development of a Measure of Patient Satisfaction with Monitored Anesthesia CareAnesthesiology, 1997
- The Validity and Reproducibility of a Work Productivity and Activity Impairment InstrumentPharmacoEconomics, 1993
- EuroQol - a new facility for the measurement of health-related quality of lifeHealth Policy, 1990